文献速递系统性红斑狼疮

系统性红斑狼疮神经精神事件的发生与缓解预测因素:国际起始队列纵向分析

Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception Cohort.
PubMed 文献 · Arthritis Rheumatol · 2021-10-29

基于1827例系统性红斑狼疮(SLE)患者的国际前瞻性起始队列,采用多状态模型分析神经精神(NP)事件的发生与缓解预测因素。NP事件发生于955例(52.3%),1910个独特事件中593个(31.0%)归因于SLE。归因于SLE的NP事件缓解率高于非SLE NP事件(头痛除外),不同归因与性质的事件病程差异显著。

要点

  • SLE相关NP事件的发生与男性、活动性SLE、糖皮质激素使用正相关,与亚洲种族、高等教育、免疫抑制剂或抗疟药治疗负相关。
  • 归因于SLE的NP事件缓解率高于非SLE NP事件,但头痛在两者中缓解率相当。
  • SLE相关NP事件的缓解在亚洲种族及中枢/局灶性NP事件中更常见。

核心结论

  • SLE病程中NP事件的发生与缓解因事件性质和归因不同而差异显著,并识别出预后较好与较差的亚组。

研究设计与样本

  • 国际前瞻性SLE起始队列,纳入1827例患者,入组时及此后每年记录归因于SLE和非SLE原因的NP事件及医生判定的缓解,采用多状态模型结构进行时间-事件分析。

主要发现

  • NP事件发生于955/1827例(52.3%)患者,593/1910个(31.0%)独特事件归因于SLE。
  • SLE相关NP事件发生与男性(P=0.028)、并发非SLE NP事件(不含头痛,P<0.001)、活动性SLE(P=0.012)、糖皮质激素使用(P=0.008)正相关。
  • SLE相关NP事件发生与亚洲种族(P=0.002)、高等教育(P=0.001)、免疫抑制剂治疗(P=0.019)及抗疟药治疗(P=0.056)负相关。
  • 非SLE NP事件(不含头痛)发生与并发SLE NP事件正相关(P<0.001),与非洲种族(P=0.012)及亚洲种族(P<0.001)负相关。
  • SLE相关NP事件缓解在亚洲种族(P=0.006)及中枢/局灶性NP事件(P<0.001)中更常见;非SLE NP事件缓解在非洲种族(P=0.017)中更常见,在SLE诊断时年龄较大者中较少见(P<0.001)。

关键数值与推荐

  • NP事件发生于52.3%(955/1827)患者,SLE归因事件占31.0%(593/1910)。
  • SLE相关NP事件发生正相关因素:男性P=0.028、并发非SLE NP事件P<0.001、活动性SLE P=0.012、糖皮质激素使用P=0.008。
  • SLE相关NP事件发生负相关因素:亚洲种族P=0.002、高等教育P=0.001、免疫抑制剂P=0.019、抗疟药P=0.056。
  • SLE相关NP事件缓解更常见于亚洲种族P=0.006及中枢/局灶性NP事件P<0.001;非SLE NP事件缓解更常见于非洲种族P=0.017,较少见于诊断时年龄较大者P<0.001。

临床怎么用

  • 对SLE患者应关注NP事件归因,SLE相关NP事件在男性、活动性SLE及使用糖皮质激素者中更易发生。
  • 亚洲种族及中枢/局灶性SLE相关NP事件缓解可能性更高,可据此进行预后评估与随访。
  • 免疫抑制剂或抗疟药治疗与SLE相关NP事件发生减少相关,但需结合原文关联性解读。

局限性

  • 原文摘要未报告具体局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine predictors of change in neuropsychiatric (NP) event status in a large, prospective, international inception cohort of patients with systemic lupus erythematosus (SLE). METHODS: Upon enrollment and annually thereafter, NP events attributed to SLE and non-SLE causes and physician-determined resolution were documented. Factors potentially associated with the onset and resolution of NP events were determined by time-to-event analysis using a multistate modeling structure. RESULTS: NP events occurred in 955 (52.3%) of 1,827 patients, and 593 (31.0%) of 1,910 unique events were attributed to SLE. For SLE-associated NP (SLE NP) events, multivariate analysis revealed a positive association with male sex (P = 0.028), concurrent non-SLE NP events excluding headache (P < 0.001), active SLE (P = 0.012), and glucocorticoid use (P = 0.008). There was a negative association with Asian race (P = 0.002), postsecondary education (P = 0.001), and treatment with immunosuppressive drugs (P = 0.019) or antimalarial drugs (P = 0.056). For non-SLE NP events excluding headache, there was a positive association with concurrent SLE NP events (P < 0.001) and a negative association with African race (P = 0.012) and Asian race (P < 0.001). NP events attributed to SLE had a higher resolution rate than non-SLE NP events, with the exception of headache, which had comparable resolution rates. For SLE NP events, multivariate analysis revealed that resolution was more common in patients of Asian race (P = 0.006) and for central/focal NP events (P < 0.001). For non-SLE NP events, resolution was more common in patients of African race (P = 0.017) and less common in patients who were older at SLE diagnosis (P < 0.001). CONCLUSION: In a large and long-term study of the occurrence and resolution of NP events in SLE, we identified subgroups with better and worse prognosis. The course of NP events differs greatly depending on their nature and attribution.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Hanly JG, Gordon C, Bae SC, et al. Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception Cohort. Arthritis Rheumatol. 2021. PMID: 34042329. doi:10.1002/art.41876

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。